Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial. [electronic resource]
Producer: 20140331Description: 429-39 p. digitalISSN:- 1479-683X
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- prevention & control
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Double-Blind Method
- Fasting
- Glucocorticoids
- Glucose Intolerance -- prevention & control
- Humans
- Insulin Resistance
- Islets of Langerhans -- drug effects
- Male
- Metabolic Syndrome -- drug therapy
- Middle Aged
- Postprandial Period -- physiology
- Prednisolone -- therapeutic use
- Pyrazines -- therapeutic use
- Sitagliptin Phosphate
- Triazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.